Modulation of Plasma Lipid Levels Affects Benzo[a]Pyrene-Induced DNA Damage in Tissues of Two Hyperlipidemic Mouse Models

Environmental and Molecular Mutagenesis

Volumn 42, Issue 4, 2003, Pages 243-249

  Curfs, Daniëlle M J ^a   Beckers, Linda ^a   Godschalk, Roger W L ^a,b   Gijbels, Marion J J ^c   Van Schooten, Frederik J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Apolipoprotein E; Benzo a pyrene; Chronic degenerative diseases; DNA adduct; Plasma lipids

Indexed keywords

APOLIPOPROTEIN E; BENZO[A]PYRENE; CARCINOGEN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYCYCLIC AROMATIC HYDROCARBON; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHRONIC DISEASE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA ADDUCT; DNA DAMAGE; GENOTYPE; HYPERLIPIDEMIA; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; BENZO(A)PYRENE; CARCINOGENS; DISEASE MODELS, ANIMAL; DNA; DNA ADDUCTS; DNA DAMAGE; HYPERLIPIDEMIAS; LIPIDS; MALE; MICE; MICE, KNOCKOUT; PYRENES; REGRESSION ANALYSIS; TIME FACTORS; TISSUE DISTRIBUTION; TRIGLYCERIDES;

ANIMALIA;

EID: 0346098196     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10200     Document Type: Article

References (26)

1. Binkova B, Strejc P, Boubelik O, Stavkova Z, Chvatalova I, Sram RJ. 2001. DNA adducts and human atherosclerotic lesions. Int J Hyg Environ Health 1:49-54.
2. Binkova B, Smerhovsky Z, Strejc P, Boubelik O, Stavkova Z, Chvatalova I, Sram RJ. 2002. DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat Res 1/2:115-128.
3. De Flora S, Izzotti A, Randerath K, Randerath E, Bartsch H, Nair J, Balansky R, van Schooten F, Degan P, Fronza G, Walsh D, Lewtas J. 1996. DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine. Mutat Res 3:197-238.
4. Djousse L, Myers RH, Province MA, Hunt SC, Eckfeldt JH, Evans G, Peacock JM, Ellison RC, 2002. Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke 5:1357-1361.
5. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. 2002. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review, Am J Epidemiol 6:487-495.
6. Fazio S, Linton MF. 2001. Mouse models of hyperlipidemia and atherosclerosis. Front Biosci 6:D515-525.
7. -/- mice. Atherosclerosis 1:49-55.
8. 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene. Chem Biol Interact 1:41-54.
9. Godschalk R, Nair J, van Schooten FJ, Risch A, Drings P, Kayser K, Dienemann H, Bartsch H. 2002. Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking. Carcinogenesis 12:2081-2086.
10. Hansen ES. 1990. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atheroscterosis-a review of the epidemiological evidence. Mutat Res 3:163-179.
11. Izzotti A, De Flora S, Petrilli GL, Gallagher J, Rojas M, Alexandrov K, Bartsch H, Lewtas J. 1995. Cancer biomarker in human atherosclerotic lesions: detection of DNA adducts. Cancer Epidemiol Biomarkers Prev 2:105-110.
12. Izzotti A, Camoirano A, Cariglia C, Tampa E, De Flora S. 2001. Formation of DNA adducts in the aorta of smoke-exposed rats, and modulation by chemopreventive agents. Mutat Res 97-106.
13. Juchau MR, Bond JA, Benditt EP. 1976, Aryl 4-monooxygenase and cytochrome P-450 in the aorta: possible role in atherosclerosis. Proc Natl Acad Sci USA 10:3723-3725.
14. Jump DB, Clarke SD. 1999. Regulation of gene expression by dietary fat. Annu Rev Nutr 19:63-90.
15. Karvonen J, Kauma H, Kervinen K, Ukkola O, Rantala M, Paivansalo M, Savolainen MJ, Kesaniemi YA. 2002. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens 12:2371-2378.
16. Liu S, Ma J, Ridker PM, Breslow JL, Stampfer MJ. 2003. A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men. Atherosclerosis 2:323-329.
17. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. 2001. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res 7:733-739.
18. Mensenkamp AR, van Luyn MJ, van Goor H, Bloks V, Apostel F, Greeve J, Hofker MH, Jong MC, van Vlijmen BJ, Havekes LM, Kuipers F. 2000. Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice. J Hepatol 2:189-198.
19. Mulder M, Blokland A, van den Berg DJ, Schulten H, Bakker AH, Terwel D, Honig W, de Kloet ER, Havekes LM, Steinbusch HW, de Lange EC. 2001. Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging. Lab Invest 7:953-960.
20. Perkins KA. 1985. The synergistic effect of smoking and serum cholesterol on coronary heart disease. Health Psychol 4:337-360.
21. Reddy MV, Randerath K. 1986. Nuclease P1-mediated enhancement of sensitivity of 32p-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 9:1543-1551.
22. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS. 2001. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann NY Acad Sci 271-292.
23. Stavenow L, Pessah-Rasmussen H. 1988. Effects of polycyclic aromatic hydrocarbons on proliferation, collagen secretion and viability of arterial smooth muscle cells in culture. Artery 2:94-108.
24. Van Nieuwkerk CM, Elferink RP, Groen AK, Ottenhoff R, Tytgat GN, Dingemans KP, Van Den Bergh Weerman MA, Offerhaus GJ. 1996. Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1:165-171.
25. Van Schooten FJ, Hirvonen A, Maas LM, De Mol BA, Kleinjans JC, Bell DA, Durrer JD. 1998. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J 13:1409-1417.
26. Yoo JS, Norman JO, Busbee DL. 1984. Benzo[a]pyrene uptake by serum lipids: correlation with triglyceride concentration. Proc Soc Exp Biol Med 3:434-440.